MALLINCKRODT UK FINANCE LLP

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

Phase 3
Completed
Conditions
Interventions
First Posted Date
2007-10-25
Last Posted Date
2020-06-17
Lead Sponsor
Mallinckrodt
Target Recruit Count
459
Registration Number
NCT00549042

Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2007-09-19
Last Posted Date
2016-10-19
Lead Sponsor
Mallinckrodt
Registration Number
NCT00531856
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

Universtiy of CA, San Francisco, San Francisco, California, United States

Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric Inpatients

Phase 1
Completed
Conditions
Interventions
First Posted Date
2007-06-28
Last Posted Date
2016-10-21
Lead Sponsor
Mallinckrodt
Target Recruit Count
75
Registration Number
NCT00493246
Locations
🇺🇸

CS Mott Childrens Hospital, Ann Arbor, Michigan, United States

🇺🇸

Lucile Packard Children's Hospital, Stanford, California, United States

🇺🇸

Duke University Health Systems, Durham, North Carolina, United States

and more 2 locations

Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males

First Posted Date
2007-06-28
Last Posted Date
2016-10-19
Lead Sponsor
Mallinckrodt
Target Recruit Count
60
Registration Number
NCT00493311
Locations
🇺🇸

Scirex Research Center, Austin, Texas, United States

Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery

First Posted Date
2006-11-15
Last Posted Date
2016-10-21
Lead Sponsor
Mallinckrodt
Target Recruit Count
331
Registration Number
NCT00399568
Locations
🇺🇸

Stony Brook Anesthesiology Health Sciences Cente, Stony Brook, New York, United States

🇺🇸

Allegheny Pain Managment, Altoona, Pennsylvania, United States

🇺🇸

Weill Medical College, New York, New York, United States

and more 24 locations

Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease

First Posted Date
2006-01-26
Last Posted Date
2017-08-16
Lead Sponsor
Mallinckrodt
Target Recruit Count
19
Registration Number
NCT00282503
Locations
🇩🇪

University of Rostock, Rostock, Germany

🇧🇪

University Hospital Gasthuisberg, Leuven, Belgium

🇧🇪

Centre Hopitalier Universitaire Sart Tilman Liege, Liege, Belgium

and more 32 locations

Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease

First Posted Date
2005-09-22
Last Posted Date
2016-10-19
Lead Sponsor
Mallinckrodt
Target Recruit Count
25
Registration Number
NCT00221026
Locations
🇺🇸

Morristown Memorial Hospital, Morristown, New Jersey, United States

🇧🇪

Hospital Erasme/ULB, Brussels, Belgium

🇩🇪

Universitat St Josef, Bochum, Germany

and more 12 locations

Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis

Phase 2
Completed
Conditions
First Posted Date
2005-09-22
Last Posted Date
2016-10-19
Lead Sponsor
Mallinckrodt
Target Recruit Count
86
Registration Number
NCT00221000
Locations
🇺🇸

Clinical Pharmacology Study Group, Worchester, Massachusetts, United States

🇮🇹

Universita de Genova - Ospedale S. Martino, Genova, Italy

🇺🇸

Carolina Arthritis Associates, Wilmington, North Carolina, United States

and more 29 locations

Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises

Phase 2
Completed
Conditions
Interventions
First Posted Date
2004-10-28
Last Posted Date
2020-02-05
Lead Sponsor
Mallinckrodt
Target Recruit Count
150
Registration Number
NCT00094887
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

Colorado Sickle Cell Treatement and Research Center, Aurora, Colorado, United States

and more 8 locations

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Phase 3
Completed
Conditions
Interventions
First Posted Date
2004-08-09
Last Posted Date
2017-10-27
Lead Sponsor
Mallinckrodt
Target Recruit Count
112
Registration Number
NCT00089570
Locations
🇺🇸

Northwestern Memorial Hospital, Chicago, Illinois, United States

🇺🇸

University of Medicine & Dentistry of New Jersey - NJMS, Newark, New Jersey, United States

🇺🇸

Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States

and more 34 locations
© Copyright 2024. All Rights Reserved by MedPath